← Eichor
Condition: Neonatal Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Neonatal Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome
Phase 1 · 1 location(s) · Johns Hopkins University · NCT06283355
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Phase 1/Phase 2 · 1 location(s) · Children's Hospital of Philadelphia · NCT06839456
Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort
Phase N/A · 9 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT06762002
Population Pharmacokinetic of Piperacillin/Tazobactam in Maternal and Neonatal Populations
Phase N/A · 1 location(s) · Shandong University · NCT06076200
Molecular Culture for the Diagnosis of Pediatric Sepsis
Phase N/A · 2 location(s) · Jip Groen · NCT06018792
Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
Phase N/A · 1 location(s) · Murdoch Childrens Research Institute · NCT05394363
The BEGIN Study Bifidobacterium Infantis to Newborns: Effects of Modulating the Gut Microbial Composition on Growth, Imm
NA · 2 location(s) · University of Aarhus · NCT06452199
Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
Phase N/A · 21 location(s) · Radboud University Medical Center · NCT00825929
A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers
Phase 1 · 1 location(s) · Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. · NCT06082323
Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung Infection
Phase 1 · 2 location(s) · Ghady Haidar · NCT07275905
Azithromycin and Ampicillin for Late PPROM
Phase 4 · 1 location(s) · Sheba Medical Center · NCT07183462
The Role of Volatile Organic Compounds (VOCs), Airway Mucins and the Microbiome in the Early Prediction of Bronchopulmon
Phase N/A · 1 location(s) · University Hospital, Antwerp · NCT06342752
Perinatal Covid-19 Infection, NO Pathway, and Minipuberty
Phase N/A · 2 location(s) · University Hospital, Lille · NCT04952870
Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral
Phase N/A · 2 location(s) · Michael Hoelscher · NCT06267508
Comparing Infectious Morbidity Among Women With Meconium-stained Amniotic Fluid at Term, Between Those Treated With Prop
NA · 1 location(s) · Western Galilee Hospital-Nahariya · NCT06849037
Natural History Study of GATA2 Deficiency and Related Disorders
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01905826
HCAPPED I: HCAP-Pcr in Emergency Department
Phase N/A · 1 location(s) · Azienda Ospedaliero-Universitaria Careggi · NCT06506617
National Longitudinal Cohort of Hematological Diseases
Phase N/A · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04645199
NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT05017766
Salivary Biomarkers in Periodontal Disease Progression
Phase N/A · 1 location(s) · Suleyman Demirel University · NCT07661784
Remote Sputum Collection in Cystic Fibrosis
Phase N/A · 3 location(s) · University of Pennsylvania · NCT06950892
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Phase 2 · 1 location(s) · Vanderbilt University Medical Center · NCT05288790
Studies of Disorders With Increased Susceptibility to Fungal Infections
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01222741
COVID-19 Antibody Responses In Cystic Fibrosis
Phase N/A · 1 location(s) · Pilar Azevedo · NCT06274840
Comprehensive Ambulatory Antibiotics for the Treatment of Congenital Syphilis
Phase 2 · 3 location(s) · London School of Hygiene and Tropical Medicine · NCT06921213
Patterns of Neurodevelopmental Disorders
Phase N/A · 1 location(s) · Richard Frye · NCT06213090
Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among High-risk
NA · 24 location(s) · PENTA Foundation · NCT05993442
A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to S
Phase 1 · 1 location(s) · Shanghai Qilu Pharmaceutical Research and Development Center · NCT06946641
CMV CTLs in Neonates With CMV Infection
Phase 2 · 4 location(s) · New York Medical College · NCT05564598
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
Phase 2 · 8 location(s) · New York Medical College · NCT03266653
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.